ArticleCureus2025
Risk Factors and Outcomes in Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Bidirectional Clinical Interactions among Exacerbations and Comorbidities in COPD: A Narrative Review.Seminars in respiratory and critical care medicine · 2026Review
- Article
- Development and evaluation of a clinical prediction model for in-hospital mortality in patients with acute exacerbation of chronic obstructive pulmonary disease.Journal of thoracic disease · 2026Article
- Development and Internal Validation of a Multivariable Prognostic Model for in-Hospital Mortality in Critically Ill Patients with Acute Exacerbation of COPD.International journal of chronic obstructive pulmonary disease · 2026Observational
- Construction and internal-external validation of a machine learning-based risk prediction model for multidrug resistance in ICU patients with acute exacerbation of chronic obstructive pulmonary disease.Frontiers in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) is a common cause of hospitalization and is associated with significant morbidity, mortality, and healthcare burden. Objectives To determine the risk factors and in-hospital outcomes in patients admitted with acute exacerbation of COPD. Methodology This retrospective analysis was conducted at Mayo Hospital, Lahore, Pakistan, from January 2022 to January 2025. A total of 355 patients were enrolled using a non-probability consecutive sampling technique. Demographic details (age, gender, smoking status, residence), clinical history (duration of COPD, previous exacerbations, comorbidities such as diabetes and hypertension), presenting symptoms, and initial investigations, including arterial blood gases, complete blood count, chest X-ray, and C-reactive protein, were recorded. Results The mean age of patients was 64.8 ± 9.5 years, with a male predominance of 226(63.7%). A majority, 271(76.3%), were chronic smokers. Common comorbidities included hypertension 148(41.7%), diabetes mellitus 104(29.3%), and ischemic heart disease (IHD) 47(13.2%). Non-invasive ventilation was required in 137(38.6%) of cases, while 48(13.5%) needed invasive mechanical ventilation. ICU admission was required in 67(18.9%) of patients. In-hospital mortality occurred in 34(9.5%) of patients. Significant predictors of poor outcomes included older age (>70 years), IHD, high baseline dyspnea score, and requirement for mechanical ventilation (p < 0.05). Conclusion AECOPD leads to high hospitalization and mortality rates, particularly among elderly patients and those with comorbidities like IHD and diabetes. Identifying modifiable risk factors can help improve survival and reduce complications in these patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.